"Unsealing" is about to talk about "immunity"
Release time:
2020-07-15
On March 24, the Hubei Province Novel Coronavirus Infection Pneumonia Epidemic Prevention and Control Headquarters issued a notice: From 0:00 on March 25, areas outside Wuhan City will be lifted from the control of the exit channel; from 0:00 on April 8, Wuhan City will lift the control measures of the exit channel from Han and Hubei. On March 25, Wuhan's first "subway to spring" resumed operation. Hubei "restart", Wuhan "unsealed", officially entered the countdown.
The "epidemic" of the war has brought irreparable pain to the Chinese people and caused huge losses to the Chinese economy. At present, "unsealing" is imminent, we should also calm down and seriously reflect on how to face all kinds of uncertain and sudden tests in the future.
As the director of the Department of Infectious Diseases of Huashan Hospital Affiliated to Fudan University and the leader of the Shanghai Medical Treatment Expert Group, Dr. Zhang Wenhong, "New Internet Celebrity", has repeatedly stated, "Before the special antiviral drugs come out, the most effective drug It is human immunity. Now what the medical staff do is not only to help all the patients who come in for treatment and isolate the virus, but also to help the patients survive for two weeks. After two weeks, the patient's own antibodies will rise. The doctor's job is to help the patient get through this stage."
Indeed, in the face of the "undifferentiated blow" of the new coronavirus, some people are fine, some are sick; some of the sick people, some have recovered smoothly, some have died unfortunately; some have recovered quickly, some have recovered slowly. The difference of individual immunity formed by age, physical fitness, hygiene habits and other factors has played a decisive role in this "war epidemic" without specific drugs.
Similar to the epidemic in life, the unprecedented long economic shutdown has also brought another sense of epidemic to many businesses. The extended holiday is not over yet, and a succession of companies have posted announcements of bankruptcy and closure on the Internet, and there are even more people struggling on the line of life and death. Some experts have pointed out that the epidemic has broken the established work arrangements of almost all enterprises, and the resulting changes in the internal and external environment may be a watershed for many enterprises.
Usually in the operation of the enterprise, almost every enterprise manager will say that it is necessary to strengthen internal control, reduce costs and increase efficiency. However, when the development of the industry and the market is in good times, many things that are not in place will be covered up. When the market growth is not obvious or decline, what does the enterprise adjust? Rely on efficiency, rely on layout. If you do the same thing faster and earlier than others, you will become active; if you layout different things earlier and faster, you will get the first opportunity.
In a crisis, survival is the key, and to be able to survive, one of the ways out is model innovation. Business models, business models, operation and management models, and work models all need innovation. Because the epidemic prevention and control needs to delay the resumption of work, many enterprises to start the "new construction" mode, so that employees at home, online, on the job to start work or study, to help employees with the new work mode to enter the working state. The remote online work model not only solves the problem of delayed resumption of work but also provides a new possibility for a large number of employees eager to return to work and enter a normal life.
The epidemic has completely changed the external environment in which companies operate, and most of the business models and business models that companies were familiar with before the epidemic may not be appropriate in the face of the epidemic. Even many companies that are themselves online models will encounter various unprecedented challenges such as affordability, technical capabilities, rapid response capabilities, changes in the industrial chain and value network, which require companies to abandon the original model and create new models. If the company is still relying on the traditional model for development and does not make a fundamental change, its development will be restricted or even eliminated; if it can quickly transform itself, turn the crisis into self-change, and seek opportunities for new development, it will Usher in a new development.
With the unremitting efforts of scientists, a specific medicine will be born one day, allowing us to firmly "lock the new coronavirus in a cage"; but for companies, when and in what way the future test will come It is always unknown to what extent, and there will never be a specific medicine to treat the company's diseases. If you want to successfully survive the various "epidemics" that will inevitably exist in the future ", we can only constantly" exercise "and improve the" immunity "of enterprises". (one word)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page